Citadel Advisors’s Adagene ADAG Stock Holding History
Bought
Maintained
Sold
Other funds holding ADAG
EAM
HH
MCCA
SP
KSCM
PAP
DIG
Citadel Advisors's ADAG Position: Q1 2026 in Review
Citadel Advisors sold out of Adagene (ADAG) in Q1 2026, closing a stake of 48,385 shares — an estimated $91.4K sold.
Citadel Advisors first reported a position in ADAG in Q1 2021 and held it in 6 quarters. The position peaked at $402K in Q1 2021. 25 funds tracked by Wall St. Rank hold ADAG as of Q1 2026.
- Citadel Advisors reported no remaining Adagene position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 48,385 Adagene shares in Q1 2026, an estimated $91.4K.
- Citadel Advisors first reported a position in Adagene in Q1 2021 and held it in 6 quarters.
- Citadel Advisors's Adagene position peaked at $402K in Q1 2021.
- 25 funds tracked by Wall St. Rank held Adagene as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.